Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShort-Term Debt repayments
Ratios

Gain Therapeutics (GANX) Long-Term Debt Issuances (2020)

Gain Therapeutics (GANX) has 1 years of Long-Term Debt Issuances data on record, last reported at $30396.0 in Q4 2020.

  • For Q4 2020, Long-Term Debt Issuances changed N/A year-over-year to $30396.0; the TTM value through Dec 2020 reached $738282.0, changed N/A, while the annual FY2020 figure was $738282.0, N/A changed from the prior year.
  • Long-Term Debt Issuances reached $30396.0 in Q4 2020 per GANX's latest filing, down from $423288.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $423288.0 in Q3 2020 and bottomed at $30396.0 in Q4 2020.